Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Projections for the CAGR of the Human Chorionic Gonadotropin Market Size From 2025 to 2034?
The market size for human chorionic gonadotropin has witnessed significant growth in the past years. It will expand from $0.95 billion in 2024 to $1.02 billion in 2025, with a compound annual growth rate (CAGR) of 8.4%. The historical progression can be credited to an increased prevalence of hypogonadism among the aging population, heightened awareness of HCG among medical professionals and patients, a growing trend of fertility tourism, an upsurge in the senior population, and improved affordability and enhancement in healthcare facilities.
The market size of human chorionic gonadotropin is anticipated to witness a solid increase in the upcoming years. It is projected to surge up to$1.41 billion by 2029″ with a compound annual growth rate (CAGR) of 8.2%. The upward trajectory during the forecast period can be associated with the escalating rates of infertility, growing instances of polycystic ovary syndrome, increased cases of female infertility, and higher application of HCG in animal medicine. Significant trends for the forecast period encompass advancements in detecting pregnancy, the introduction of innovative drug formulations, incorporation of technology, emphasis on research and development, and breakthroughs in product innovation.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp
What are the Fundamental Drivers and Innovations Shaping the Human Chorionic Gonadotropin Market?
The upward trend in infertility rates is predicted to fuel the expansion of the human chorionic gonadotropin market. Infertility, defined as the incapacity to get pregnant after at least a year of regular, unprotected sex, is on the rise due to more individuals and couples facing conception issues. These challenges stem from delayed childbearing, lifestyle shifts, environmental factors, and health conditions. Human chorionic gonadotropin (hCG) plays a crucial role in infertility treatments, its primary functions being to trigger ovulation in women and enhance testosterone production in men, which aids in egg release and enriches fertility results. Case in point, the World Health Organization, based in Switzerland, reported in April 2023 that about 17.5% of the global adult populace, equivalent to one in every six people worldwide, suffered from infertility. This underscores the urgent necessity to enhance access to affordable, top-notch fertility care for those in distress. Consequently, the rise in infertility rates is a significant propellant for the growth of the human chorionic gonadotropin market.
How Is the Human Chorionic Gonadotropin Market Segmented?
The human chorionic gonadotropinmarket covered in this report is segmented –
1) By Technology: Natural Source Extraction; Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment; Oligospermic Treatment; Male Hypogonadism; Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Fertility Clinics; Research Institutions; Other End Users
Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women’s Urine; Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg; Recombinant Hcg For Therapeutic Use; Recombinant Hcg For Diagnostic Applications
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=18638&type=smp
Which Regions Are Driving the Next Phase of the Human Chorionic Gonadotropin Market Growth?
North America was the largest region in the human chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Human Chorionic Gonadotropin Market?
Leading entities within the human chorionic gonadotropin market are prioritizing the creation of novel products, including pregnancy detection kits, to enhance diagnostic precision, improve patient results, and broaden their market footprint. Pregnancy detection kits serve as devices verifying a person’s pregnancy status by identifying human chorionic gonadotropin (hCG) in their system. For example, in June 2022, Proov, a medical equipment manufacturing firm based in the US, introduced new hCG tests tailored for early pregnancy confirmation. This allows women to determine their pregnancy state up to six days prior to their anticipated menstruation. These tests work by detecting human chorionic gonadotropin (hCG) in the urine and are marked by their exceptional accuracy, boasting a trustworthiness score of over 99. This innovative measure aims to offer women a reliable and readily available means of tracking their pregnancy status sooner than conventional tests, equipping them with the necessary knowledge to make well-informed choices concerning their reproductive health.
View the full report here:
https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report
How Is the Human Chorionic Gonadotropin Market Defined and What Are Its Core Parameters?
Human chorionic gonadotropin (hCG) is a hormone produced during pregnancy. It is produced by the placenta shortly after the embryo implants in the uterus. hCG plays a critical role in maintaining pregnancy by stimulating the corpus luteum (a structure in the ovary) to produce progesterone, which supports the uterine lining and prevents it from breaking down.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18638
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model